Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Remission maintenance by tioguanine in chronic active Crohn's disease.

Alimentary pharmacology & therapeutics - 15 Jun 2003

Herrlinger K R, Deibert P, Schwab M, Kreisel W, Fischer C, Fellermann K, Stange E F

Abstract excerpt

BACKGROUND: Tioguanine may offer an alternative for immunosuppression in chronic active Crohn's disease. Recently, we have shown that tioguanine is effective in inducing rapid remission. AIM: To evaluate the role of tioguanine in the maintenance of remission in chronic active Crohn's disease. METHODS: A follow-up study was performed to investigate the long-term efficacy and safety of and tolerance to tioguanine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Antimetabolites, Antineoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chronic Disease

Share to Crohn Disease

Share to Erythrocytes

Share to Methyltransferases

Share to Steroids

Share to Thioguanine

Source

Identifiers

PMID: 12823147
DOI: 10.1046/j.1365-2036.2003.01590.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Remission maintenance by tioguanine in chronic active Crohn's disease.PMID 12823147Read ↗

6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.Semantic proximity Read ↗

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis.Semantic proximity Read ↗

Crohn's disease.Semantic proximity Read ↗

Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.Semantic proximity Read ↗

Effective long-term solution to therapeutic remission in Inflammatory Bowel Disease: Role of Azathioprine.Semantic proximity Read ↗

Thiopurine-induced pancreatitis in inflammatory bowel diseases.Semantic proximity Read ↗

Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.Semantic proximity Read ↗

Review article: practical management of inflammatory bowel disease patients taking immunomodulators.Semantic proximity Read ↗

Severe pancytopenia from thiopurine methyltransferase deficiency: a preventable complication of 6-mercaptopurine therapy in children with Crohn disease.Semantic proximity Read ↗

Omega-3 fatty acids as adjunctive therapy in Crohns disease.Semantic proximity Read ↗

6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.Semantic proximity Read ↗

Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.